Acuta Capital Partners as of Dec. 31, 2022
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 34 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aadi Bioscience (AADI) | 12.1 | $20M | 1.8M | 10.61 | |
| Miragen Therapeutics (VRDN) | 7.1 | $12M | 397k | 29.21 | |
| Apellis Pharmaceuticals (APLS) | 6.9 | $11M | 218k | 51.71 | |
| Terns Pharmaceuticals (TERN) | 6.9 | $11M | 1.1M | 10.18 | |
| United Therapeutics Corporation (UTHR) | 5.6 | $9.2M | 33k | 278.09 | |
| Sarepta Therapeutics (SRPT) | 5.4 | $8.7M | 68k | 129.58 | |
| Syndax Pharmaceuticals (SNDX) | 5.1 | $8.3M | 325k | 25.45 | |
| Iveric Bio | 4.7 | $7.7M | 361k | 21.41 | |
| Ventyx Biosciences (VTYX) | 4.7 | $7.6M | 291k | 26.02 | |
| Vaxcyte (PCVX) | 4.3 | $6.9M | 145k | 47.95 | |
| Cymabay Therapeutics | 3.9 | $6.4M | 1.0M | 6.27 | |
| Kura Oncology (KURA) | 3.8 | $6.2M | 502k | 12.41 | |
| Mersana Therapeutics (MRSN) | 3.4 | $5.6M | 950k | 5.86 | |
| Bellus Health Com New | 3.2 | $5.2M | 633k | 8.22 | |
| Celldex Therapeutics Com New (CLDX) | 3.2 | $5.1M | 115k | 44.57 | |
| Rocket Pharmaceuticals (RCKT) | 3.1 | $5.1M | 260k | 19.57 | |
| Bioatla (BCAB) | 2.5 | $4.1M | 500k | 8.25 | |
| Aclaris Therapeutics (ACRS) | 2.5 | $4.0M | 255k | 15.75 | |
| Keros Therapeutics (KROS) | 2.4 | $3.8M | 80k | 48.02 | |
| Gh Research Ordinary Shares (GHRS) | 1.5 | $2.4M | 243k | 9.72 | |
| Argen Se Sponsored Adr (ARGX) | 1.2 | $1.9M | 5.1k | 378.83 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.0 | $1.7M | 41k | 40.56 | |
| Fulcrum Therapeutics (FULC) | 0.8 | $1.3M | 185k | 7.28 | |
| Pmv Pharmaceuticals (PMVP) | 0.8 | $1.3M | 155k | 8.70 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.7 | $1.1M | 303k | 3.50 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $982k | 154k | 6.39 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $982k | 94k | 10.50 | |
| Pyxis Oncology Common Stock (PYXS) | 0.6 | $897k | 669k | 1.34 | |
| Rezolute Com New (RZLT) | 0.5 | $869k | 420k | 2.07 | |
| Horizon Therapeutics SHS | 0.4 | $683k | 6.0k | 113.80 | |
| Prothena Corporation SHS (PRTA) | 0.3 | $560k | 9.3k | 60.25 | |
| Imara | 0.1 | $182k | 45k | 4.09 | |
| Kinnate Biopharma | 0.0 | $31k | 5.0k | 6.10 | |
| Nuvation Bio *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $13k | 91k | 0.14 |
